Efficacy of adipose stromal cells-enriched high-density fat graft combined with BTX-A for Raynaud’s phenomenon: a prospective cohort study

    March 2025 in “ Arthritis Research & Therapy ”
    Chengliang Deng, Xin Liu, Miaomiao Wei, Bihua Wu, Tianhua Zhang, Shune Xiao, Peiru Min, Yixin Zhang
    The study investigates the efficacy of combining adipose stromal cells-enriched high-density fat graft (HDFG) with botulinum toxin type A (BTX-A) for treating Raynaud’s phenomenon (RP). The results indicate that this combination is a reliable and beneficial intervention, resulting in high patient satisfaction. The study supports the use of this combined treatment approach for improving symptoms in patients with RP.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results